MUMBAI, India & PRINCETON, N.J.–(BUSINESS WIRE)– #Cequa–Sun Pharma Launches CEQUA for the Treatment of Dry Eye Disease in the U.S.
Author: Business Wire
Topcon Healthcare Selected to Ease Transition for IBM® Merge Eye Station and Merge Eye Care PACS Customers
OAKLAND, N.J.–(BUSINESS WIRE)– #AAO–Topcon Healthcare Selected to Ease Transition for IBM Watson Health Imaging Merge Eye Station and Merge Eye Care PACS Customers
New Data from Teprotumumab Phase 3 OPTIC Study Shows Significantly Reduced Double Vision and Improved Quality of Life for People with Active Thyroid Eye Disease
DUBLIN–(BUSINESS WIRE)–New data from Phase 3 teprotumumab study shows significant benefit on several devastating effects of active thyroid eye disease (TED).
Eyevensys présente les premiers résultats de son étude clinique de phase I / II évaluant une thérapie génique non virale innovante pour les maladies oculaires au 11e Sommet Annuel de l'Innovation en Ophtalmologie
SAN FRANCISCO–(BUSINESS WIRE)–Eyevensys, société privée de biotechnologie au stade clinique développant des thérapies géniques non virales pour les maladies oculaires, a présenté cette semaine les résultats de la première partie de son étude de phase…
Eyevensys Presents Initial Data from Phase I/II Trial of Innovative, Non-Viral Gene Therapy for Ocular Diseases at 11th Annual Ophthalmology Innovation Summit
SAN FRANCISCO–(BUSINESS WIRE)– #OIS2019–Eyevensys presented initial results from a phase I/II trial of its innovative, non-viral gene therapy for ocular diseases at OIS@AAO this week.
Global Ophthalmic Lens Market 2019-2023| Evolving Opportunities with Bausch Health & Essilor|Technavio
LONDON–(BUSINESS WIRE)– #Healthcare–The global ophthalmic lens market size is poised to grow by USD 13.15 billion during 2019-2023, according to a new report by Technavio.
Tej Kohli基金會宣導一種可擴展、易取得且平價的技術解決方案來終結全球角膜失明
倫敦–(BUSINESS WIRE)–(美國商業資訊)–在世界視力日，Tej Kohli基金會表示，必須專注於新技術，才能加快在全世界終結可治癒角膜失明的全球使命。基金會目前正在資助臨床試驗和一種液態生物合成(liquid biosynthetic)解決方案的開發，該解決方案可望提供易於取得、可擴展且平價的角膜失明解決方案，這種解決方案對於全世界1200萬角膜失明患者中的許多人是極為重要的。 Tej Kohli基金會的論點是，人工智慧、機器人和基因體學等指數級成長的技術將大幅促進全世界的人道主…
Tej Kohli基金会倡导一种可扩展、易获取且平价的技术解决方案来终结全球角膜失明
伦敦–(BUSINESS WIRE)–(美国商业资讯)–在世界视力日，Tej Kohli基金会表示，必须专注于新技术，才能加快在全世界终结可治愈角膜失明的全球使命。基金会目前正在资助临床试验和一种“液态生物合成”解决方案的开发，该解决方案有望提供易获取、可扩展且平价的角膜失明解决方案，这种解决方案对于全世界1200万角膜失明患者中的许多人是至关重要的。 Tej Kohli基金会的论点是，人工智能、机器人和基因组学等指数级成长的技术将大幅促进全世界的人道主义努力。基金会的行为类似风投资金，即支持…
Harbour BioMed Announces Completion of Phase 2 Study in China of HBM9036 In Patients With Moderate-to-Severe Dry Eye Disease
CAMBRIDGE, Mass. & ROTTERDAM, The Netherlands & SHANGHAI–(BUSINESS WIRE)–Harbour BioMed Announces Completion of Phase 2 Study in China of HBM9036 in Patients with Moderate-to-Severe Dry Eye Disease
PanOptica Anti-VEGF Eye Drop Shows Promise in Treatment of Neovascular (Wet) AMD
MOUNT ARLINGTON, N.J.–(BUSINESS WIRE)–PanOptica reported positive and unprecedented clinical data for PAN-90806, a once-daily topical eye drop, at OIS@AAO.
Aerpio Pharmaceuticals Announces Interim Results from its Phase 1b Clinical Trial of Topical Ocular Formulation of AKB-9778 for Primary Open Angle Glaucoma
CINCINNATI–(BUSINESS WIRE)–Aerpio Pharmaceuticals, Inc. (Nasdaq:ARPO), a biopharmaceutical company focused on developing compounds that activate Tie2 to treat ocular diseases and diabetic complications, today announced interim results from its Phase …
Ophthalmology Times® Releases 2019 Best Programs Survey Results
CRANBURY, N.J.–(BUSINESS WIRE)– #clinicalprogram–Ophthalmology Times® Releases 2019 Best Programs Survey Results
La Fondation Tej Kohli prône la mise au point d'une solution technologique abordable, accessible et évolutive pour éradiquer la cécité cornéenne dans le monde entier
LONDRES–(BUSINESS WIRE)–En cette journée mondiale de la vue, la Fondation Tej Kohli fait savoir qu’il est nécessaire d’axer les efforts sur les nouvelles technologies afin d’accélérer la mission internationale dont elle s’est investie, consistant à é…
Eyenuk Receives NIH Grant To Expand AI Eye Screening Platform for Neurodegenerative Disease Detection
LOS ANGELES–(BUSINESS WIRE)–Eyenuk Inc. has been awarded a grant to develop a retinal image AI solution for the detection of biomarkers for neurodegenerative disorders.
Compulink Launches E-Commerce Solution for its All-in-One Ophthalmology EHR at AAO 2019
NEWBURY PARK, Calif.–(BUSINESS WIRE)–Compulink launches e-commerce solution for its all-in-one ophthalmology EHR at AAO 2019.
For World Sight Day, Horizon and Prevent Blindness Are Calling on the Thyroid Eye Disease (TED) Community to Put “Vision First”
DUBLIN–(BUSINESS WIRE)–For World Sight Day, Horizon Therapeutics and Prevent Blindness are calling on the thyroid eye disease (TED) community to put “vision first.”
Tej Kohli Foundation engagiert sich für eine skalierbare, zugängliche und erschwingliche Technologielösung zur weltweiten Beseitigung der hornhautbedingten Erblindung
LONDON–(BUSINESS WIRE)–Am Welttag des Sehens (World Sight Day) verkündet die Tej Kohli Foundation, dass ein Fokus auf neue Technologien notwendig ist, um die weltweite Mission zur Beseitigung der hornhautbedingten Erblindung verstärkt verfolgen zu kö…
Fundação Tej Kohli defende uma solução de tecnologia escalável e acessível para acabar com a cegueira corneana no mundo todo
LONDRES–(BUSINESS WIRE)–No Dia Mundial da Visão, a Fundação Tej Kohli afirma que é necessário um foco em novas tecnologias para acelerar a missão global de acabar com a cegueira corneana curável no mundo inteiro. Atualmente, a Fundação está financian…
La Tej Kohli Foundation promuove una soluzione tecnologica scalabile, accessibile e conveniente per eliminare la cecità corneale nel mondo
LONDRA–(BUSINESS WIRE)–In concomitanza con la Giornata mondiale della vista, la Tej Kohli Foundation ha dichiarato che è necessario concentrarsi su nuove tecnologie per accelerare la missione globale che punta a eradicare la cecità corneale curabile …
La Fundación Tej Kohli aboga por una solución tecnológica escalable, accesible y asequible para curar la ceguera corneal en todo el mundo
LONDRES–(BUSINESS WIRE)–En el Día Mundial de la Visión, la Fundación Tej Kohli afirma que es necesario centrarse en las nuevas tecnologías para acelerar la misión mundial de poner fin a la ceguera corneal curable en todo el mundo. Actualmente, la Fun…